Indications: Respitrol^® is indicated for use in adults aged 18 years and older for long-term maintenance therapy of bronchial patency disorders in patients with chronic obstructive pulmonary disease (COPD).

This product is included in the Essential Drug List (EDL).

Prescription Status: Rx (prescription) only.

THERE ARE CONTRAINDICATIONS. PLEASE CONSULT A HEALTHCARE PROFESSIONAL BEFORE USE.

For the full medical use instructions of Respitrol^® (Indacaterol), inhalation powder hard capsule, 150 mcg, 300 mcg, please visit the official website: grls.rosminzdrav.ru (https://grls.rosminzdrav.ru/Default.aspx)